Literature DB >> 24588384

Recombinant expression of antimicrobial peptides using a novel self-cleaving aggregation tag in Escherichia coli.

Chao Luan1, Yong Gang Xie, Yu Tian Pu, Hai Wen Zhang, Fei Fei Han, Jie Feng, Yi Zhen Wang.   

Abstract

Antimicrobial peptides (AMPs) are part of the innate immune system of complex multicellular organisms. Despite the fact that AMPs show great potential as a novel class of antibiotics, the lack of a cost-effective means for their mass production limits both basic research and clinical use. In this work, we describe a novel expression system for the production of antimicrobial peptides in Escherichia coli by combining ΔI-CM mini-intein with the self-assembling amphipathic peptide 18A to drive the formation of active aggregates. Two AMPs, human β-defensin 2 and LL-37, were fused to the self-cleaving tag and expressed as active protein aggregates. The active aggregates were recovered by centrifugation and the intact antimicrobial peptides were released into solution by an intein-mediated cleavage reaction in cleaving buffer (phosphate-buffered saline supplemented with 40 mmol/L Bis-Tris, 2 mmol/L EDTA, pH 6.2). The peptides were further purified by cation-exchange chromatography. Peptides yields of 0.82 ± 0.24 and 0.59 ± 0.11 mg/L were achieved for human β-defensin 2 and LL-37, respectively, with demonstrated antimicrobial activity. Using our expression system, intact antimicrobial peptides were recovered by simple centrifugation from active protein aggregates after the intein-mediated cleavage reaction. Thus, we provide an economical and efficient way to produce intact antimicrobial peptides in E. coli.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24588384     DOI: 10.1139/cjm-2013-0652

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  5 in total

1.  Recombinant production of influenza hemagglutinin and HIV-1 GP120 antigenic peptides using a cleavable self-aggregating tag.

Authors:  Wanghui Xu; Qing Zhao; Lei Xing; Zhanglin Lin
Journal:  Sci Rep       Date:  2016-11-03       Impact factor: 4.379

Review 2.  Perspectives for clinical use of engineered human host defense antimicrobial peptides.

Authors:  María Eugenia Pachón-Ibáñez; Younes Smani; Jerónimo Pachón; Javier Sánchez-Céspedes
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

Review 3.  Cathelicidins: Immunomodulatory Antimicrobials.

Authors:  Roel M van Harten; Esther van Woudenbergh; Albert van Dijk; Henk P Haagsman
Journal:  Vaccines (Basel)       Date:  2018-09-14

Review 4.  Antimicrobial Peptides: Recent Insights on Biotechnological Interventions and Future Perspectives.

Authors:  Rajeshwari Sinha; Pratyoosh Shukla
Journal:  Protein Pept Lett       Date:  2019       Impact factor: 1.890

5.  Active tyrosine phenol-lyase aggregates induced by terminally attached functional peptides in Escherichia coli.

Authors:  Hongmei Han; Weizhu Zeng; Guoqiang Zhang; Jingwen Zhou
Journal:  J Ind Microbiol Biotechnol       Date:  2020-07-31       Impact factor: 3.346

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.